Records containing: Metastatic Breast Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-02-12A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase II Study of the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trastuzumab and Taxane Based Therapy
-
CLINICAL_TRIALS study record update · 2019-02-06Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
-
CLINICAL_TRIALS study record update · 2019-02-01A Phase 1/2 Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Seviteronel in Subjects With Advanced Breast Cancer
-
CLINICAL_TRIALS study record update · 2019-01-31Impact of Electronic Treatment Plans on Shared Decision Making for Metastatic Breast Cancer: An Educational/Research Initiative
-
CLINICAL_TRIALS study record update · 2019-01-09A Phase III Randomized, Double Blind, Placebo Controlled Study of BKM120 With Fulvestrant, in Postmenopausal Women With Hormone Receptor-positive HER2-negative AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTOR Inhibitor Based Treatment
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-01-09SOLTI Molecular Screening Program: a Pilot Study to Implement Personalized Therapy for Patients With Advanced or Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-12-28Phase Ib Dose Escalating Study to Evaluate the Safety, Tolerability and Pharmacodynamic Response of Foxy-5 in Patients With Metastatic Breast-, Colon- or Prostate Cancer
-
CLINICAL_TRIALS study record update · 2018-12-05A Phase II Study of Eribulin Mesylate in Combination With Trastuzumab and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-11-07A Two Arm Pilot Study Utilizing Molecular Profiling to Find Potential Targets and Influence Treatments for Patients With Metastatic Breast Cancer or Advanced Gynecological Malignancies
-
CLINICAL_TRIALS study record update · 2018-11-02Evaluation Of CanADVICE+®M-Health System To Support Breast Cancer Patients Receiving Capecitabine
-
CLINICAL_TRIALS study record update · 2018-09-14A Phase I Dose Escalation Study of POL6326 With Eribulin in Patients With Relapsed, Triple Negative and Hormone Refractory ER Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-07-27Lapatinib in Endocrine-Resistant Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-07-23Role of Fulvestrant in The Treatment of Metastatic Breast Cancer in Premenopausal Women
-
CLINICAL_TRIALS study record update · 2018-07-20Quantitative Targeted Proteomics Detected by Mass Spectrometry With Whole Genome (DNA) and Whole Transcriptome (RNA) Sequencing in Advanced Cancers
-
CLINICAL_TRIALS study record update · 2018-07-20A Phase II Trial of Trastuzumab, Neupogen, and Vinorelbine Investigating the Effects on Immune Function and Clinical Outcomes in Patients With Metastatic Breast Cancer Overexpressing Her-2/Neu
-
CLINICAL_TRIALS study record update · 2018-07-20ClinicalTrials.gov study NCT02939274
-
CLINICAL_TRIALS study record update · 2018-07-09A Phase I Study of Pyrotinib In Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-06-20Non-Interventional Study to Investigate Efficacy and Safety of Nab-Paclitaxel in Patients With Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-06-06Phase 2 Randomized, Multicenter Study of IMC-A12 as a Single Agent or in Combination With Antiestrogens in Postmenopausal Women With Hormone Receptor-Positive Advanced or Metastatic Breast Cancer After Progression on Antiestrogen Therapy
-
CLINICAL_TRIALS study record update · 2018-05-22A Randomised Phase II Study of Carboplatin With or Without the Addition of the ETAR Inhibitor ZD4054 as Treatment for Patients With Metastatic Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-05-18A Phase I Study of the Safety and Tolerability of Single Agent MSI-1436C in Metastatic Breast Cancer Patients
-
CLINICAL_TRIALS study record update · 2018-05-18ClinicalTrials.gov study NCT01910870
-
CLINICAL_TRIALS study record update · 2018-05-07Phase II Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
-
CLINICAL_TRIALS study record update · 2018-04-30Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Fulvestrant (Faslodex) Plus Everolimus in Post-Menopausal Patients With Hormone-Receptor Positive Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy
-
CLINICAL_TRIALS study record update · 2018-04-20A Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer